Loading...
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
A randomized phase II trial was performed to compare the efficacy and toxicity of interleukin 2 (IL-2) with an IL-2 and interferon alpha (IFN-alpha) regimen for the treatment of metastatic renal carcinoma. Sixty patients with recurrent renal cell carcinoma (RCC) who had previously undergone a nephre...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group|1
1998
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2063040/ https://ncbi.nlm.nih.gov/pubmed/9703284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|